QuantumScape Corporation (NYSE:QS – Get Free Report) insider Mohit Singh sold 325,000 shares of QuantumScape stock in a transaction dated Thursday, June 26th. The stock was sold at an average price of $7.21, for a total value of $2,343,250.00. Following the sale, the insider now directly owns 1,641,711 shares of the company’s stock, valued at $11,836,736.31. This trade represents a 16.53% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website.
Mohit Singh also recently made the following trade(s):
- On Wednesday, June 25th, Mohit Singh sold 290,000 shares of QuantumScape stock. The stock was sold at an average price of $5.96, for a total value of $1,728,400.00.
- On Monday, May 19th, Mohit Singh sold 71,428 shares of QuantumScape stock. The stock was sold at an average price of $4.41, for a total value of $314,997.48.
QuantumScape Stock Down 13.5%
QuantumScape stock opened at $6.62 on Friday. QuantumScape Corporation has a fifty-two week low of $3.40 and a fifty-two week high of $9.52. The company has a debt-to-equity ratio of 0.03, a quick ratio of 16.66 and a current ratio of 16.66. The company has a market capitalization of $3.70 billion, a P/E ratio of -7.27 and a beta of 4.27. The stock has a 50-day simple moving average of $4.28 and a 200-day simple moving average of $4.63.
Institutional Trading of QuantumScape
Several institutional investors and hedge funds have recently added to or reduced their stakes in QS. Sanctuary Advisors LLC raised its stake in QuantumScape by 4.0% during the 4th quarter. Sanctuary Advisors LLC now owns 168,256 shares of the company’s stock valued at $875,000 after acquiring an additional 6,475 shares during the last quarter. Private Advisor Group LLC raised its stake in QuantumScape by 47.3% during the 4th quarter. Private Advisor Group LLC now owns 61,356 shares of the company’s stock valued at $318,000 after acquiring an additional 19,704 shares during the last quarter. Ieq Capital LLC raised its stake in QuantumScape by 2.6% during the 4th quarter. Ieq Capital LLC now owns 87,370 shares of the company’s stock valued at $453,000 after acquiring an additional 2,200 shares during the last quarter. Handelsbanken Fonder AB raised its stake in QuantumScape by 2.0% during the 4th quarter. Handelsbanken Fonder AB now owns 114,700 shares of the company’s stock valued at $595,000 after acquiring an additional 2,300 shares during the last quarter. Finally, Y Intercept Hong Kong Ltd purchased a new stake in QuantumScape during the 4th quarter valued at approximately $1,275,000. 29.87% of the stock is owned by hedge funds and other institutional investors.
Wall Street Analysts Forecast Growth
A number of analysts have issued reports on the company. The Goldman Sachs Group decreased their price target on QuantumScape from $3.00 to $2.50 and set a “sell” rating for the company in a report on Monday, April 28th. Robert W. Baird decreased their price target on QuantumScape from $8.00 to $6.00 and set a “neutral” rating for the company in a report on Thursday, April 24th. Finally, UBS Group downgraded QuantumScape from a “neutral” rating to a “sell” rating and decreased their price target for the stock from $5.00 to $2.50 in a report on Thursday, April 10th. Three research analysts have rated the stock with a sell rating and six have assigned a hold rating to the stock. Based on data from MarketBeat, the stock has an average rating of “Hold” and an average target price of $5.19.
QuantumScape Company Profile
QuantumScape Corporation, a research and development stage company, focuses on the development and commercialization of solid-state lithium-metal batteries for electric vehicles and other applications. The company was founded in 2010 and is headquartered in San Jose, California.
Read More
- Five stocks we like better than QuantumScape
- How to Calculate Return on Investment (ROI)
- Apple: The Mag 7’s Dead Money Stock or AI Cash Cow in the Making?
- Stocks with Unusual Volume: How to Find Unusual Volume Stocks in Real Time
- Value Alert: 3 High-Yield Stocks Trading at 52-Week Lows
- What is a Bond Market Holiday? How to Invest and Trade
- Nektar Jumps 157% on Drug Trial Data—Can It Go Even Higher?
Receive News & Ratings for QuantumScape Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for QuantumScape and related companies with MarketBeat.com's FREE daily email newsletter.